PTC Therapeutics is a global biopharmaceutical company from the USA that focuses on innovative small molecules and gene therapies for rare genetic diseases such as Duchenne muscular dystrophy (DMD) or AADC deficiency. Children as patients are a special challenge for society and, of course, also for the doctors treating them. Life Science Communication supports PTC Therapeutics in disease awareness activities in the regions Europe and Middle East.